作者: M Del Zompo , Alessio Squassina , G. P. Patrinos
DOI:
关键词:
摘要: Bipolar disorder is a mental disease which characterized by major episodes alternating between maniacal and depressive states, affect 1 to 5% of the population, prevalently treated with lithium salts. Not all patients, however respond this treatment. The described invention relates method for pharmacogenetic assessment response treatment salts in patients bipolar based on detection polymorphism located intron amiloride-sensitive cation channel 1, neuronal gene (ACCN1 ).